<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/E89C3602-0FB4-4044-A918-58966B8A10B2"><gtr:id>E89C3602-0FB4-4044-A918-58966B8A10B2</gtr:id><gtr:name>University of Reading</gtr:name><gtr:department>Sch of Biological Sciences</gtr:department><gtr:address><gtr:line1>Whiteknights House</gtr:line1><gtr:line2>PO Box 217</gtr:line2><gtr:line4>Reading</gtr:line4><gtr:line5>Berkshire</gtr:line5><gtr:postCode>RG6 6AH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E89C3602-0FB4-4044-A918-58966B8A10B2"><gtr:id>E89C3602-0FB4-4044-A918-58966B8A10B2</gtr:id><gtr:name>University of Reading</gtr:name><gtr:address><gtr:line1>Whiteknights House</gtr:line1><gtr:line2>PO Box 217</gtr:line2><gtr:line4>Reading</gtr:line4><gtr:line5>Berkshire</gtr:line5><gtr:postCode>RG6 6AH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/69EB87D9-C073-4D26-897C-787ACA6BC8DF"><gtr:id>69EB87D9-C073-4D26-897C-787ACA6BC8DF</gtr:id><gtr:firstName>Jonathan</gtr:firstName><gtr:otherNames>Martin</gtr:otherNames><gtr:surname>Gibbins</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0701399"><gtr:id>4280B6A8-D918-4668-A0EB-A96EA5708CC1</gtr:id><gtr:title>Study of the role of secreted platelet thiol isomerases in the regulation of platelet function, haemostasis &amp;amp; thrombosis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701399</gtr:grantReference><gtr:abstractText>Platelets are tiny blood cells whose role is to trigger the blood to clot when blood vessels become ruptured during injury. While this is clearly essential to prevent excessive and life-threatening bleeding, abnormal stimulation of blood clotting can be catastrophic, particularly if this leads to the clotting of blood within an artery or vein. This is a condition know as thrombosis, and when this happens in arteries that supply the heart muscle with blood it can cause a heart attack. Thrombosis also commonly occurs in the blood vessels that supply the brain with blood, and in this case it causes strokes. Both of these conditions are very common in the UK and are frequently fatal. The cause of thrombosis in these situations is often underlying diseases such as the formation of fatty lesions in the wall of blood vessels that are liable to rupture, but platelets are ultimately responsible for triggering a dangerous clot to form. The use of drugs to dampen down the responses of platelets has been successful in many ?at risk? patients in the prevention of thrombosis, although many patients gain no benefit and may even suffer side effects such as bleeding. In order to develop better drugs that target platelets to prevent thrombosis, scientists need to know more about how platelets recognise injury, and then stimulate the blood to clot. In this research project we will investigate some proteins that we have found to be released by platelets when they encounter tissue injury. We know that once released some of these molecules attach themselves to the platelet surface and somehow enhance the platelet clotting activity. The purpose of this study is to work out which of the proteins that are released are important to control platelets and how they work. We will also determine whether these molecules contribute to thrombosis using new experimental procedures. It is anticipated that this project will equip us with a new understanding of how platelets regulate their functions the identification of the molecules involved. This knowledge may lead, in future studies, to the development of more effective drugs to successfully prevent thrombosis.</gtr:abstractText><gtr:technicalSummary>Platelets perform a vital role in haemostasis, although inappropriate platelet activation, for example at the site of a ruptured atherosclerotic lesion, causes arterial thrombosis leading to heart attacks and strokes. While substantial progress has been made in recent years in the treatment and prevention of thrombosis, there remains a substantial unmet clinical demand. Understanding of the complex mechanisms through which the function of platelets is regulated is important for the development of more effective strategies to prevent arterial thrombosis. We have reported previously that during platelet activation, which leads to aggregation and thrombus formation, platelets release ERp5, a member of the thiol isomerase family of enzymes. This protein interacts with the platelet surface, whereupon its enzymic activity enhances platelet function. While the molecular mechanisms have yet to be defined, protein disulphide isomerase (PDI), the best characterised thiol isomerase, is also secreted from platelets and influences their reactivity. Extra-cellular PDI has also been recently implicated in the regulation of tissue factor, which triggers coagulation following exposure and de-encryption at sites of injury. In preliminary studies we have identified additional platelet thiol isomerases, some of which are also secreted during activation. 
The aims of this study are to characterise systematically the range thiol iomerases that are released from platelets during activation; to establish the potential roles of individual secreted thiol isomerases in the regulation of platelet function in vitro; to determine the identity of platelet surface substrates for these enzymes which will begin to explain their individual or collective mechanisms of action; and to establish the abilities of each in the regulation of thrombus formation in vivo using mouse models of thrombosis. This study will involve the generation of a panel of novel antibody-based reagents that will enable the specific inhibition of secreted thiol isomerases, and will employ a wide range of cell biology and biochemical approaches to study the function of platelets in vitro and in vivo. 
Data from this project will provide a detailed and systematic understanding of the individual and collective roles of secreted thiol iomerases at the platelet surface, and the substrates through which they exert their actions. Understanding of this new paradigm for the regulation of thrombus formation may lead to the identification of new targets for the pharmacological suppression of platelets, which may include selected thiol isomerases themselves, that may result through continued studies in the generation of more effective anti-thrombotic therapies.</gtr:technicalSummary><gtr:fund><gtr:end>2011-12-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>500003</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Toronto</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>WK University of Toronto</gtr:description><gtr:id>CB0CDDB0-050E-42B8-833A-BC0E074CD477</gtr:id><gtr:impact>too early - the work forms the basis of studies within the new award that has developed from this project</gtr:impact><gtr:partnerContribution>The collaborator is providing unique expertise and training in the use of microscopy techniques to be implemented in my lab</gtr:partnerContribution><gtr:piContribution>We have provided unique reagents and generated the research questions to be explored</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Bristish Science Festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B5C64ABC-2C73-436F-94C0-F76F7D5492E9</gtr:id><gtr:impact>Around 50 people attended the talk which covered various elements of cardiovascular disease, its prevention and treatment. This enabled me to include how scientists tackle complex patho-physiological questions and the techniques that we develop to do this. Within this funding contract we have developed new intravital techniques to stimulate, visualise and quantify thrombosis in the mouse, and this was incorporated into my talk.

I received a number of informed questions. Following the success of the session and the general interest expressed by the audience, I was invited to take part in an unusual session at the end of the conference when I was interviewed by a BBC journalist in from of an audience in a bar - stand up science! This was an excellent way to present important developments to the public in an easily accessible form and included scientists from a wide range of disciplines.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Children's lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>BF97A174-7E3A-48FA-A4E9-28A52A85D92F</gtr:id><gtr:impact>approximately 400 children attended a talk on blood, which included some basic elements of this research. It was at a simple levels, and incorporated demonstrations, relevant creatures, and audience participation in all elements. This caused a great deal of excitement, and numerous subsequent questions and inquiries.

I have been contacted by a number of teachers, and will in the future follow this up with School visits (which I do periodically).</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>195787</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>8E08F59F-E4BB-4D66-B032-DF5691B2D69E</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>937000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Programme Grant</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>RG/09/011/28094</gtr:fundingRef><gtr:id>FBA4484A-08BF-45B1-A606-BE1F365EEDCD</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1175779</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J002666/1</gtr:fundingRef><gtr:id>09AA561D-2F48-4312-BCE3-8829CCBBA055</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have established models of thrombosis in the mouse, that are quantitatively analysed using intravital microscopy. This approach has been shared with collaborators, and is a component of several other grant awards to this and collaborators' groups. This technology will be expanded in the recently awarded grant in which this work will be developed further.</gtr:description><gtr:id>E6DE7E7B-60A7-47F0-812D-4AEC08F3CDA6</gtr:id><gtr:impact>To date this is restricted to publications.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>analysis of thrombosis in vivo</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have generated a range of antibodies that are able to selectively inhibit the activities of thiol isomerases of interest. This have been distributed widely to the research community</gtr:description><gtr:id>56EA33A7-35CD-4F77-8225-FC988FDFF8FA</gtr:id><gtr:impact>Publications</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>antibodies</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3D9DD202-AF3F-4E1C-A36E-9B9B68D1B5C9"><gtr:id>3D9DD202-AF3F-4E1C-A36E-9B9B68D1B5C9</gtr:id><gtr:title>EphB2 regulates contact-dependent and contact-independent signaling to control platelet function.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2215b214a96aeabcf3f04e48d33cd500"><gtr:id>2215b214a96aeabcf3f04e48d33cd500</gtr:id><gtr:otherNames>Vaiyapuri S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C2D14C75-7301-463C-8B63-BCACD438B45F"><gtr:id>C2D14C75-7301-463C-8B63-BCACD438B45F</gtr:id><gtr:title>Staphylococcal extracellular adherence protein induces platelet activation by stimulation of thiol isomerases.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f7d8465134e5a240ccffaf849175e8c0"><gtr:id>f7d8465134e5a240ccffaf849175e8c0</gtr:id><gtr:otherNames>Bertling A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1E61A30C-7238-4053-96C9-92EDA0C5E088"><gtr:id>1E61A30C-7238-4053-96C9-92EDA0C5E088</gtr:id><gtr:title>Pharmacological actions of nobiletin in the modulation of platelet function.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2215b214a96aeabcf3f04e48d33cd500"><gtr:id>2215b214a96aeabcf3f04e48d33cd500</gtr:id><gtr:otherNames>Vaiyapuri S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EC0E1144-A614-4A81-9DAE-91E7D93EA2C1"><gtr:id>EC0E1144-A614-4A81-9DAE-91E7D93EA2C1</gtr:id><gtr:title>Integrin-linked kinase regulates the rate of platelet activation and is essential for the formation of stable thrombi.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ce46933e340664f1feab54010e135fc9"><gtr:id>ce46933e340664f1feab54010e135fc9</gtr:id><gtr:otherNames>Jones CI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/52CF00F3-237F-4EF8-A589-C7BC1CC8C0C8"><gtr:id>52CF00F3-237F-4EF8-A589-C7BC1CC8C0C8</gtr:id><gtr:title>Platelets release novel thiol isomerase enzymes which are recruited to the cell surface following activation.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/91986e5fa3e31d4133a81b3d7fed161a"><gtr:id>91986e5fa3e31d4133a81b3d7fed161a</gtr:id><gtr:otherNames>Holbrook LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9663FA21-6192-455E-AF2A-4CFC11DC4A59"><gtr:id>9663FA21-6192-455E-AF2A-4CFC11DC4A59</gtr:id><gtr:title>Rhinocetin, a venom-derived integrin-specific antagonist inhibits collagen-induced platelet and endothelial cell functions.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2215b214a96aeabcf3f04e48d33cd500"><gtr:id>2215b214a96aeabcf3f04e48d33cd500</gtr:id><gtr:otherNames>Vaiyapuri S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1635F545-5671-4AA7-BEBE-74F834494936"><gtr:id>1635F545-5671-4AA7-BEBE-74F834494936</gtr:id><gtr:title>Platelet protein disulfide isomerase is required for thrombus formation but not for hemostasis in mice.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1857cecfd381d325a3c8a449d03b339d"><gtr:id>1857cecfd381d325a3c8a449d03b339d</gtr:id><gtr:otherNames>Kim K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/16E321D4-25C5-4D4F-B1D8-577A96716108"><gtr:id>16E321D4-25C5-4D4F-B1D8-577A96716108</gtr:id><gtr:title>The platelet-surface thiol isomerase enzyme ERp57 modulates platelet function.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/91986e5fa3e31d4133a81b3d7fed161a"><gtr:id>91986e5fa3e31d4133a81b3d7fed161a</gtr:id><gtr:otherNames>Holbrook LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8709FE97-805D-4789-B079-6F579C513087"><gtr:id>8709FE97-805D-4789-B079-6F579C513087</gtr:id><gtr:title>LXR as a novel antithrombotic target.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b23b875e5c023d046636ad7dbc65aa5e"><gtr:id>b23b875e5c023d046636ad7dbc65aa5e</gtr:id><gtr:otherNames>Spyridon M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701399</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>939798CA-B6AE-4C12-9DCC-A0F88F84E6F3</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Blood</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>